2026 NPPES data Medical Oncology Physician NPI 1205896818 M.D.
Verify on CMS →

DANIEL MILTON, M.D.

Medical Oncology Physician in INDIANAPOLIS, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 334 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$36.7K
53 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DANIEL MILTON, M.D. filed 1,649 Medicare Part D claims in 2023 as a Medical Oncology Physician in INDIANAPOLIS, Indiana, prescribing 74% generic.

2K
Part D claims, 2023
74%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DANIEL MILTON, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,649 Top 18% higher than 82% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). This entry sits in this band. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

DANIEL MILTON, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DANIEL MILTON, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/27/2006

NPI 1205896818

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

1,649 139% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Indiana

How Medical Oncology Physician compares to other specialties among Indiana providers

Indiana providers

Medical Oncology Physician share within Indiana

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Indiana

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DANIEL MILTON, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 8301 HARCOURT RD STE 200, INDIANAPOLIS, IN, 46260, with a listed phone of (317) 415-6600. NPI 1205896818 was issued on 03/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MILTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,649 prescription claims written by this provider, covering 334 Medicare beneficiaries and totaling roughly $4.8 million in drug spend, split 26% brand-name and 74% generic by claim count, with an opioid prescribing rate of 1.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8301 HARCOURT RD STE 200
INDIANAPOLIS, IN 46260

Provider Details

NPI 1205896818
Specialty Medical Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 03/27/2006

Hospital and facility affiliations

Facilities where DANIEL MILTON, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

AMERICAN ONCOLOGY PARTNERS PA
INDIANAPOLIS, IN
RIVERVIEW HOSPITAL
NOBLESVILLE, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DANIEL MILTON, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$36.7K

Largest payer

Astellas Pharma US Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

DANIEL MILTON, M.D. — brand share 26.0%
Specialty average (est.)

26% brand-name claims vs 74% generic, on 1,649 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,649
Total Claims
$4.8M
Total Drug Cost
334
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,626
Total Day Supply
73,645
Brand vs Generic
26% brand / 74% generic
Brand Drug Cost
$4.6M
Generic Drug Cost
$250K
Opioid Claims
18 (1.1% rate)
Antibiotic Claims
17

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
2.19
Gender Split
63% female / 37% male
Age Distribution
<65: 17, 65-74: 148, 75-84: 127, 85+: 42

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DANIEL MILTON, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
211
Eliquis
Apixaban
99
Hydroxyurea
96
Tamoxifen Citrate
93
Prednisone
83
Dexamethasone
80
Letrozole
65
Ondansetron Odt
Ondansetron
65
Revlimid
Lenalidomide
64
Warfarin Sodium
51

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How DANIEL MILTON, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

DANIEL MILTON, M.D.'s 1,649 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as MILTON.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DANIEL MILTON, M.D.'s specialty?
DANIEL MILTON, M.D. specializes in Medical Oncology Physician and practices in INDIANAPOLIS, Indiana. Credentials: M.D..
How much does DANIEL MILTON, M.D. prescribe under Medicare Part D?
In 2023, DANIEL MILTON, M.D. wrote 1,649 Medicare Part D claims totaling $4.8M in drug costs for 334 beneficiaries.
Where is DANIEL MILTON, M.D. located?
DANIEL MILTON, M.D. is located at 8301 HARCOURT RD STE 200, INDIANAPOLIS, IN, 46260. Phone: (317) 415-6600.
What is DANIEL MILTON, M.D.'s NPI number?
DANIEL MILTON, M.D.'s National Provider Identifier (NPI) is 1205896818, issued on 03/27/2006.
Does DANIEL MILTON, M.D. prescribe more brand-name or generic drugs?
DANIEL MILTON, M.D.'s prescribing is 26% brand-name and 74% generic drugs by claim count, with $4.6M in brand drug costs.
Does DANIEL MILTON, M.D. prescribe opioids?
Yes, DANIEL MILTON, M.D. had 18 opioid claims in 2023 with an opioid prescribing rate of 1.1%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does DANIEL MILTON, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DANIEL MILTON, M.D.'s most frequently prescribed drugs include Anastrozole, Eliquis, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DANIEL MILTON, M.D. accept Medicare?
DANIEL MILTON, M.D. appears in CMS Medicare data with 1,649 Part D claims and 334 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DANIEL MILTON, M.D.'s credentials?
DANIEL MILTON, M.D.'s NPI is 1205896818 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology